Kingswood Wealth Advisors LLC Has $2.38 Million Stock Position in Humana Inc. (NYSE:HUM)

Kingswood Wealth Advisors LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 23.0% during the fourth quarter, HoldingsChannel reports. The fund owned 9,379 shares of the insurance provider’s stock after buying an additional 1,751 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Humana were worth $2,380,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of HUM. State Street Corp raised its stake in Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after buying an additional 53,272 shares during the period. FMR LLC grew its holdings in Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Pzena Investment Management LLC grew its holdings in Humana by 8.1% during the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after purchasing an additional 187,903 shares during the period. Ontario Teachers Pension Plan Board grew its holdings in Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after purchasing an additional 71,910 shares during the period. Finally, Sanders Capital LLC boosted its holdings in shares of Humana by 1.0% in the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock worth $370,060,000 after acquiring an additional 11,923 shares during the period. Institutional investors own 92.38% of the company’s stock.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.32% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on HUM shares. Morgan Stanley increased their price objective on Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. UBS Group decreased their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, October 4th. Barclays raised their target price on Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 22nd. Finally, TD Cowen lifted their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $297.68.

Humana Trading Up 0.2 %

Shares of Humana stock opened at $294.47 on Monday. The firm has a 50-day simple moving average of $274.39 and a two-hundred day simple moving average of $304.79. The company has a market cap of $35.46 billion, a P/E ratio of 26.08, a price-to-earnings-growth ratio of 2.15 and a beta of 0.55. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. As a group, equities analysts predict that Humana Inc. will post 16.11 earnings per share for the current fiscal year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.